The functionality of HLA-G is emerging

Immunological Reviews

Volumn 167, Issue , 1999, Pages 233-244

  Bouteiller, Philippe Le ^a   Blaschitz, Astrid ^b  

^a CHU PURPAN   (France)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HLA G ANTIGEN;

AMNION FLUID; ANGIOGENESIS; ANTIGEN PRESENTATION; ARTICLE; CHORION VILLUS; CYTOTROPHOBLAST; ENDOTHELIUM CELL; FEMALE; HISTOCOMPATIBILITY GENE; HUMAN; MAMMAL; NATURAL KILLER CELL; NONHUMAN; PLACENTA; PREGNANCY; PRIORITY JOURNAL;

EID: 0032928059     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1999.tb01396.x     Document Type: Article

References (64)

1. 1. Ellis SA, Sargent IL, Redman CW, McMichael AJ. Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line. Immunology 1986;59:595-601.
2. 2. Geraghty DE, Koller BH, Orr HT. A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc Natl Acad Sci USA 1987;84:9145-9149.
3. 3. Le Bouteiller P. HLA class I chromosomal region, genes, and products: facts and questions. Crit Rev Immunol 1994;14:89-129.
4. 4. Lanier LL. Follow the leader: NK cell receptors for classical and nonclassical MHC class I. Cell 1998;92:705-707.
5. 5. Leibson PJ. Cytotoxic lymphocyte recognition of HLA-E: utilizing a nonclassical window to peer into classical MHC. Immunity 1998;9:289-294.
6. 6. O'Callaghan C, Bell JI. Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G. Immunol Rev 1998;163:129-138.
7. 7. Le Bouteiller P, Lenfant F. Antigen-presenting function(s) of the non-classical HLA-E, -F and -G class I molecules: the beginning of a story. Res Immunol 1996;147:301-313.
8. 8. Van den Elsen PJ, Peijnenburg A, van Eggermond MC, Gobin SJ. Shared regulatory elements in the promoters of MHC class I and class II genes. Immunol Today 1998;19:308-312.
9. 9. Hunt JS, Chu W, Miller L. Nonspecific immunity in the uterus and placenta. Trophoblast Res 1998;12:125-134.
10. Vega MA, Strominger JI. Constitutive endocytosis of HLA class I antigens requires a specific portion of the intracytoplasmic tail that shares structural features with other endocytosed molecules. Proc Natl Acad Sci USA 1989;86:2688-2692.
11. 11. Davis DM, Reyburn HT, Pazmany L, Chiu I, Mandelboim O, Strominger JL. Impaired spontaneous endocytosis of HLA-G. Eur J Immunol 1997;27:2714-2719.
12. 12. Fujii T, Ishitani A, Geraghty DE. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol 1994;153:5516-5524.
13. 13. Kirszenbaum M, Moreau P, Gluckman E, Dausset J, Carosella E. An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc Natl Acad Sci USA 1994;91:4209-4213.
14. 14. Loke YW, King A. Human implantation: cell biology and immunology. Cambridge: Cambridge University Press; 1995.
15. 15. Hunt JS. HLA and the maternal-fetal relationship. Austin (TX): RG Landes Company; 1996.
16. 16. Bensussan A, et al. Detection of membranebound HLA-G translated products with a specific monoclonal antibody. Proc Natl Acad Sci USA 1995;92:10292-10296.
17. 17. Lee N, et al. The membrane-bound and soluble forms of HLA G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 1995;3:591-600.
18. 18. McMaster MT, et al. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol 1995;154:3771-3778.
19. 19. Loke YW, et al. Evaluation of trophoblast HLA-G antigen with a specific monoclonal antibody. Tissue Antigens 1997;50:135-146.
20. 20. Chu W, Fant ME, Geraghty DE, Hunt JS. Soluble HLA-G in human placentas: synthesis in trophoblasts and interferon gamma activated macrophages but not placental fibroblasts. Hum Immunol 1998;59:435-442.
21. 21. McMaster M, et al. HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation. J Immunol 1998;160:5922-5928.
22. 22. Blaschitz A, et al. Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G. Eur J Immunol 1997;27:3380-3388.
23. 23. Yang Y, Chu W, Geraghty DE, Hunt JS. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-γ. J Immunol 1996;156:4224-4231.
24. 24. Lee N, Goodlett DR, Ishitani A, Marquardt H, Geraghty DE. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J Immunol 1998;160:4951-4960.
25. 25. Amiot L, et al. HLA-G transcription studies during the different stages of normal and malignant hematopoiesis. Tissue Antigens 1996;48:609-614.
26. 26. Paul P, et al. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA 1998;95:4510-4515.
27. 27. Jurisicova A, Casper RF, MacLusky NJ, Mills GB, Librach CL. HLA-G expression during preimplantation human embryo development. Proc Natl Acad Sci USA 1996;93:161-165.
28. 28. Crisa L, McMaster MT, Ishii JK, Fisher SJ, Salomon DR. Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J Exp Med 1997;186:289-298.
29. 29. Amiot L, Onno M, Drenou B, Monvoisin C, Fauchet R. HLA-G class I gene expression in normal and malignant hematopoietic cells. Hum Immunol 1998;59:524-528.
30. 30. Diehl M, et al. Nonclassical HLA-G molecules are classical peptide presenters. Curr Biol 1996;6:305-314.
31. 31. Braud V, Jones EY, McMichael A. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol 1997;27:1164-1169.
32. 32. Braud VM, Allan DS, Wilson D, McMichael AJ. TAP-and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr Biol 1998;8:1-10.
33. 33. Koller BH, Geraghty DE, Shimizu Y, DeMars R, Orr HT. HLA-E: a novel HLA class I gene expressed in resting T cells. J Immunol;141:897-904.
34. 34. Boyson JE, Iwanaga KK, Golos TG, Watkins DI. Identification of a novel MHC class I gene. Mamu-AG, expressed in the placenta of a primate with an inactivated G locus. J Immunol 1997;159:3311-3321.
35. 35. Schmidt CM, Garrett E, Orr HT. Cytotoxic T lymphocyte recognition of HLA-G in mice. Hum Immunol 1997;55:127-139.
36. 36. Horuzsko A, Antoniou J, Tomlinson P, Portik-Dobos V, Mellor AL. HLA-G functions as a restriction element and a transplantation antigen in mice. Int Immunol 1997;9:645-653.
37. 37. Schust DJ, Hill AB, Ploegh HL. Herpes simplex virus blocks intracellular transport of HLA-G in placentally derived human cells. J Immunol 1996;157:3375-3380.
38. 38. Fox H. The placenta and infection. In: Redman CWG, Sargent IL, Stakkey PM, eds. The human placenta. Oxford: Blackwell Scientific Publication; 1993. p. 313-333.
39. 39. King A, et al. Evidence for the expression of HLA-C class I mRNA and protein by human first trimester trophoblast. J Immunol 1996;156:2068-2076.
40. 40. Ober C, Aldrich CL. HLA-G polymorphisms: neutral evolution or novel function? J Reprod Immunol 1997;36:1-21.
41. 41. Arnaiz-Villena A, et al. Primate Mhc-E and -G alleles. Immunogenetics 1997;46:251-266.
42. 42. Moretta A, et al. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev 1997;155:105-117.
43. 43. Mandelboim O, et al. Multiple receptors for HLA-G on human natural killer cells. Proc Natl Acad Sci USA 1997;94:14666-14670.
44. 44. Colonna M, et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 1997;186:1809-1818.
45. 45. Navarro F, et al. The ILT2 (LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules coexpressed on target cells. Eur J Immunol 1999;29:277-283.
46. 46. Colonna M, et al. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 1998;160:3096-3100.
47. 47. Cantoni C, et al. p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily. Eur J Immunol 1998;28:1980-1990.
48. 48. Pende D, et al. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex. Eur J Immunol 1997;27:1875-1880.
49. 49. Perez-Villar JJ, et al. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. J Immunol 1997;158:5736-5743.
50. 50. Söderstrom K, Corliss B, Lanier LL, Phillips JH. CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells. J Immunol 1997;159:1072-1075.
51. 51. Braud VM, et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998;391:795-799.
52. 52. Lee N, et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA 1998;95:5199-5204.
53. 53. Llano M, et al. HLA-E bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur J Immunol 1998;28:2854-2863.
54. 54. Stroynowski I, Tabaczewski P. Multiple products of class Ib Qa-2 genes: which ones are functional? Res Immunol 1996;147:290-301.
55. 55. Sipes SL, et al. A new major histocompatibility complex class Ib gene expressed in the mouse blastocyst and placenta. Immunogenetics 1996;45:108-120.
56. 56. Slukvin II, Boyson JE, Watkins DI, Golos TG. The rhesus monkey analogue of human lymphocyte antigen-G is expressed primarily in villous syncytiotrophoblasts. Biol Reprod 1998;58:728-738.
57. 57. Schust DJ, Tortorella D, Seebach J, Phan C, Ploegh HL. Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. J Exp Med 1998;188:497-503.
58. 58. Guimond MJ, Wang B, Croy BA. Engraftment of bone marrow from severe combined immunodeficient (SCID) mice reverses the reproductive deficits in natural killer cell-deficient tgε 26 mice. J Exp Med 1998;187:217-223.
59. 59. Maejima M, Fujii T, Kozuma S, Okai T, Shibata Y, Taketani Y. Presence of HLA-G-expressing cells modulates the ability of peripheral blood mononuclear cells to release cytokines. Am J Reprod Immunol 1997;38:79-82.
60. 60. Tafuri A, Alferink J, Moller P, Hammerling GJ, Arnold B. T cell awareness of paternal alloantigens during pregnancy. Science 1995;270:630-633.
61. + T cells specific for paternal MHC class I accumulate during pregnancy. J Reprod Immunol 1998;40:47-62.
62. 62. King A, Gardner L, Loke YW. Human decidual leukocytes do not proliferate in response to either extravillous trophoblast or allogeneic peripheral blood lymphocytes. J Reprod Immunol 1996;30:67-74.
63. 63. Zavazava N, Kronke M. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nat Med 1996;2:1005-1010.
64. 64. Ober C, et al. HLA-G1 protein expression is not essential for fetal survival. Placenta 1998;19:127-132.